What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews
What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews
复制标题
DOI：
10.1136/bmj.329.7473.999
复制
发表时间：
2004-10-30
影响因子：
105.7
通讯作者：
Wright, J
中科院分区：
文献类型：
--
作者：
Sheldon, TA;Cullum, N;Wright, J
目的评估国家临床优化研究所（NICE）发布的指南的实施程度和模式。设计中断时间序列分析，病例记录，调查。和采访。在英格兰和威尔士设立急性和初级保健信托基金。参与者所有初级保健处方、医院药房：随机抽样20个急性信托基金、17个心理健康信托基金和21个初级保健信托基金;结果6308例可用病例中，有1000例来自五个急性病信托基金的高级临床医生和管理人员。返回了患者审计表。NICE指南的实施因信任和主题而异。紫杉烷类抗癌药物处方（P
Objectives To assess the extent and pattern of implementation of guidance issued by the National Institute for Clinical Excellence (NICE).Design Interrupted time series analysis, review of case notes, survey. and interviews.Setting Acute and primary care trusts in England and Wales.Participants All primary care prescribing, hospital pharmacies: a random sample of 20 acute trusts, 17 mental health trusts, and 21 primary care trusts; and senior clinicians and managers from five acute trusts.Main outcome measures Rates of prescribing and use of procedures and medical devices relative to evidence based guidance.Results 6308 usable patient audit forms were returned. Implementation of NICE guidance varied by trust and by topic. Prescribing of some taxanes for cancer (P